Meet
Versius Plus
Versius Plus is a surgical robot developed and engineered for versatility and adaptability, driven by a digital ecosystem embedded at its core.
Now FDA 510(k) cleared for Cholecystectomy.
510(k) submission filed for benign gynecologic indications.
Freedom to Access By Design - Versius Plus
Versius Plus is designed to expand access to robotic surgery across all care settings
Adaptable
Versatile
Through design and technology, Versius Plus delivers the precision and efficiency surgeons demand. Its integrated fluorescence visualization system, vLimeLite, enables real-time ICG imaging, delivering enhanced visual information. With a full surgical toolkit, Versius Plus is ready to transform surgical experience in the OR.
Digitally Driven
Learn more about Versius Plus
Full suite of instruments
Full suite of instruments
Enhanced vision system
Enhanced vision system
- vLimeLite, an integrated fluorescence visualization system, with multiple modes
- Powerful vision control with automatic brightness
- 26", 3DHD screen to enhance visualization
Digitally driven ecosystem
Digitally driven ecosystem
- New features and performance improvements delivered through software
- Real-time, data-driven insights via Versius Connect and Versius Team
- Clinical and operational monitoring
Massimillano Colella
Chief Executive Officer at CMR Surgical
Publications
News
CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus™ into Gynecology
CMR Surgical Announces 45,000 Patients Treated Globally as Robotic-Assisted Surgery Company Makes Its U.S. Debut
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
Disclaimer:
Versius Plus is a Robotic-Assisted Surgical Device intended to assist in the precise and accurate control of Versius Surgical endoscopic instruments and is indicated in the U.S. for adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, for cholecystectomy. For full product and safety information, please refer to Important Safety Information.
Versius Plus is 510k cleared by FDA and is approved for sale in the United States.
Versius Plus is part of a Versius ecosystem comprised of the Versius Surgical System, the EIZO CuratOR product, the vLimeLite visualization system, and a suite of electrosurgical and nonelectrosurgical instruments in the United States.
CMR Surgical, the CMR Surgical logo, vLimeLite and Versius are trademarks or registered trademarks of CMR Surgical in the UK and other jurisdictions. EIZO, the EIZO logo, and CuratOR are trademarks or registered trademarks of EIZO Corporation in Japan and other countries Indocyanine green (ICG) is a drug and is not provided by CMR Surgical and must be independently sourced by the customer. The approval status of the drug may vary by country.
The Versius System vLimeLite Instructions for Use, including the approved indications, contraindications and warnings can be found in the product labeling supplied with each Versius Plus System. The Ultrasonic Dissector is not approved for sale in the United States. Versius and its associated products are commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. Please contact your local CMR Surgical representative for product availability in your region. Refer to the product-specific user manual for indications, contraindications, warnings, and other product information. The information is correct at the time of publication of this press release.
